AGIO — Agios Pharmaceuticals Inc. stock price and chart

Share this page

AGIO

$31.32-3.09%

as of close, Oct 16, 2026

☾ AH $31.32 -3.09%

Agios Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.007%Russell 3000 0.003%US Stock Market 0.003%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

20.030.040.050.060.070.080.090.0020.0M$31.32

2026-10-16

Price$31.32

MA20$33.04

MA50$33.13

Vol6.6M

What would $1,000 invested in AGIO be worth today? →

AGIO returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $31.32
YTD price return: +15.06%
YTD total return: +15.06%
Next earnings: Nov 5, 2026 · Before open
Market cap: 1.9B2016-12 1.8B2026-10 1.9B+6.8% over the window
Enterprise value: 901M
Shares outstanding: 59.7M2016-06 38M2026-06 59.7M+56.9% over the window
52W low: $22.24
52W high: $46.00
From 52W high: -31.91%
From 52W low: +40.83%
52W range: 38%

Volume

Rel volume: 0.87×
30D volume: 1.1M
30D $ vol: 35.7M

Fundamentals

Sales (ttm): 98.3M2016-06 50M2026-06 98.3M+96.8% over the window
Sales/share: $1.652016-06 $1.312026-06 $1.65+25.4% over the window
EPS (ttm): -$7.012019-12 -$6.862026-06 -$7.01+2.2% over the window
FCF (ttm): -365.3M2016-06 72.7M2026-06 -365.3M-602.3% over the window
FCF/share: -$6.122016-06 $1.912026-06 -$6.12-420.1% over the window
Book value/share: $17.192016-06 $7.602026-06 $17.19+126.2% over the window
Net margin: -418.24%2016-06 -320.3%2026-06 -418.2%+30.6% over the window
ROE: -40.09%2016-06 -55.4%2026-06 -40.1%-27.6% over the window
ROA: -37.11%2016-06 -28.7%2026-06 -37.1%+29.3% over the window
Current ratio: 10.222016-06 7.202026-06 10.22+42.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +140.73%2025-06-30 → 2026-06-3040.9M → 98.3M (+140.6% total)+69.61%2023-06-30 → 2026-06-3020.1M → 98.3M (+388.1% total)+4.54%2021-06-30 → 2026-06-3078.8M → 98.3M (+24.9% total)+7.01%2016-06-30 → 2026-06-3050M → 98.3M (+96.8% total)
Shares: +2.76%2025-06-30 → 2026-06-3058.1M → 59.7M (+2.8% total)+2.32%2023-06-30 → 2026-06-3055.7M → 59.7M (+7.1% total)+0.25%2021-06-30 → 2026-06-3059M → 59.7M (+1.3% total)+4.61%2016-06-30 → 2026-06-3038M → 59.7M (+56.9% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +134.27%2025-06-30 → 2026-06-30$0.70 → $1.65 (+134.1% total)+65.77%2023-06-30 → 2026-06-30$0.36 → $1.65 (+355.7% total)+4.28%2021-06-30 → 2026-06-30$1.34 → $1.65 (+23.3% total)+2.29%2016-06-30 → 2026-06-30$1.31 → $1.65 (+25.4% total)
Book value/share: -27.11%2025-06-30 → 2026-06-30$23.57 → $17.19 (-27.1% total)-0.22%2023-06-30 → 2026-06-30$17.30 → $17.19 (-0.7% total)-10.06%2021-06-30 → 2026-06-30$29.21 → $17.19 (-41.2% total)+8.51%2016-06-30 → 2026-06-30$7.60 → $17.19 (+126.2% total)
Price: -24.58%2025-10-16 → 2026-10-16$41.52 → $31.32 (-24.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.66%2023-10-16 → 2026-10-16$23.11 → $31.32 (+35.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.51%2021-10-15 → 2026-10-16$46.28 → $31.32 (-32.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.13%2016-10-14 → 2026-10-16$47.78 → $31.32 (-34.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -24.58%2025-10-16 → 2026-10-16$41.52 → $31.32 (-24.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.66%2023-10-16 → 2026-10-16$23.11 → $31.32 (+35.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.51%2021-10-15 → 2026-10-16$46.28 → $31.32 (-32.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.13%2016-10-14 → 2026-10-16$47.78 → $31.32 (-34.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -4.5×2016-12 -9.602026-10 -4.55-52.6% over the window
Fwd P/E: -7.9×
P/S (ttm)Market cap ÷ TTM revenue.: 19.0×2016-12 32.792026-10 19.04-41.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.8×2016-12 4.372026-10 1.82-58.2% over the window
EV/Sales (ttm): 9.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -19.53%2016-09 2.8%2026-06 -16.5%-697.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 59.7M ÷ 58.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -2.76%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.76%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -2.76%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 -9.2%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.: 0.00%2016-09 -9.2%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S: 8th
P/B: 43rd

Bar = where today’s multiple sits in AGIO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-3.09%

-1.54%

-4.95%

-19.11%

YTD

+15.06%

-24.57%

-32.32%

Financial statements

Open full AGIO financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

AGIO — Agios Pharmaceuticals Inc. price, chart and key statistics